Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07936825
PHASE4

Intravenous LIGNOcaine for the POstoperative Sore Throat

Sponsor: University of Malaya

View on ClinicalTrials.gov

Summary

Patients often encounter unpleasant sore throat after surgery when wake up from general anaesthesia and pulling off breathing tube. Lignocaine is a medication used in anaesthesia for the properties of analgesia and anti-inflammation. Other studies suggested that lignocaine spray/ gel can reduce the postoperative sore throat after extubation in patients undergoing surgery. However, it can reduce the gag reflex, resulting in higher risk of aspiration after surgery. Therefore, this randomized, double-blind, placebo-controlled trial is designed to determine whether giving intravenous lignocaine toward the end of the surgery before extubation can reduce postoperative sore throat and discomfort after surgery. It is hypothesized that intravenous lignocaine can reduce postoperative sore throat in patients undergoing general anaesthesia.

Official title: Intravenous LIGNOcaine for the POstoperative Sore Throat: A Double-blinded Randomised Placebo-controlled Trial (LIGNO-POST Trial)

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

398

Start Date

2027-01-01

Completion Date

2027-12-31

Last Updated

2026-11-13

Healthy Volunteers

No

Interventions

DRUG

Intravenous lignocaine

IV lignocaine 1.5 mg/kg, calculated on lean body weight (LBW).

DRUG

Normal Saline (0.9% NaCl)

0.9% normal saline

Locations (1)

Universiti Malaya Medical Centre

Kuala Lumpur, Kuala Lumpur, Malaysia